Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Novartis
Harvard Business School
Daiichi Sankyo
Queensland Health
Healthtrust
Farmers Insurance
Teva
Citi
Merck

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018800

« Back to Dashboard

NDA 018800 describes BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by Abraxis Pharm, Fresenius Kabi Usa, and Hospira, and is included in three NDAs. It is available from six suppliers. Additional details are available on the BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and fifteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 018800
Tradename:BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant:Hospira
Ingredient:sodium chloride
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 018800
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 018800 NDA Hospira, Inc. 0409-1966 0409-1966-05 25 VIAL, MULTI-DOSE in 1 TRAY (0409-1966-05) > 20 mL in 1 VIAL, MULTI-DOSE (0409-1966-01)
BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride INJECTABLE;INJECTION 018800 NDA Hospira, Inc. 0409-1966 0409-1966-07 25 VIAL, MULTI-DOSE in 1 TRAY (0409-1966-07) > 30 mL in 1 VIAL, MULTI-DOSE (0409-1966-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength9MG/ML
Approval Date:Oct 29, 1982TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Farmers Insurance
Daiichi Sankyo
Chinese Patent Office
Cerilliant
Cipla
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot